Literature DB >> 24722506

Patient experience of the transition from Xalatan to generic latanoprost.

S L Painter1, A L Mead1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24722506      PMCID: PMC4094811          DOI: 10.1038/eye.2014.71

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  2 in total

1.  Are generic topical prostanoids the way forward in the care of glaucoma patients? - Yes.

Authors:  L C Titcomb
Journal:  Eye (Lond)       Date:  2013-06-28       Impact factor: 3.775

2.  Are generic topical prostanoids the way forward in the care of glaucoma patients? - No.

Authors:  V D J-P Dubois
Journal:  Eye (Lond)       Date:  2013-06-28       Impact factor: 3.775

  2 in total
  6 in total

1.  Manchester iStent study: 3-year results and cost analysis.

Authors:  S Z Tan; L Au
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

2.  Reply to: 'Glaucoma prescribing trends in England 2000 to 2012'.

Authors:  S Tiew; A Choudhary
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

3.  Intraocular pressure with rebound tonometry and effects of topical intraocular pressure reducing medications in guinea pigs.

Authors:  Yue Di; Xiu-Mei Luo; Tong Qiao; Na Lu
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

4.  Reply to 'Patient experience of the transition from Xalatan to generic latanoprost'.

Authors:  L C Titcomb
Journal:  Eye (Lond)       Date:  2014-04-11       Impact factor: 3.775

Review 5.  The Use of Generic Medications for Glaucoma.

Authors:  Andrew J Tatham
Journal:  J Ophthalmol       Date:  2020-04-07       Impact factor: 1.909

Review 6.  Generics versus brand-named drugs for glaucoma: the debate continues.

Authors:  Shibal Bhartiya; Deepika Dhingra
Journal:  Rom J Ophthalmol       Date:  2020 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.